Please assess the completion status of the following clinical trial:

Trial Title: Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Male~* History of erectile dysfunction (ED) for at least 3 months duration~* Anticipate having the same female partner willing to participate throughout the study~* At least 18 years of age at Visit 1 and agree to make at least 4 sexual attempts during the early phase of the study~* Adequate partner sexual function as determined by a Female Sexual Function Index~* Willing to record responses to efficacy questionnaires, sexual quality of life questionnaires and other instruments used in the study~Exclusion Criteria:~* May not participate in the study if you have taken tadalafil previously.~* History of cardiac conditions including angina requiring treatment with nitrates, heart disease of coronary conditions including myocardial infarction, bypass surgery, angioplasty or stent placement for specified time before starting the study.~* Have sexual partner not willing to complete the scales.~* Use of nitrates.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Placebo
- 2 (Type: ACTIVE_COMPARATOR): 5 mg tadalafil

Based on this trial design, predict the completion outcome and termination type (if applicable).